820985-23-7Relevant articles and documents
3-AMINOPYRROLIDINES AS INHIBITORS OF MONOAMINE UPTAKE
-
Page/Page column 63-64, (2008/06/13)
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, which are useful for the inhibition of the uptake of one or more physiologically active monoamines (serotonin, norepinephrine, and dopamine).
TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH NOREPINEPHRINE REUPTAKE INHIBITORS
-
Page/Page column 226, (2010/02/11)
Provided are methods and medicaments for treating a Pervasive Developmental Disorder, comprising administering to a patient in need of such treatment an effective amount of a selective norepinephrine reuptake inhibitor.